Bobby Helmedag

Bobby Helmedag

Bobby Helmedag

MANAGING DIRECTOR, REX HEALTH VENTURES

Bobby oversees the day-to-day operations of the fund. Bobby serves as the Rex Health Ventures Board representative for Midnight Pharma, Target PharmaSolutions and Phynd Technologies as well as having Board observer roles with Aerial BioPharma and Awarepoint. He joined UNC REX Healthcare in 2010. Previously, Bobby worked for BlueCross BlueShield of Tennessee in the Corporate Development group. He has also held positions with an investor group in Columbia, S.C., Citigroup and KPMG. Bobby received his International MBA from the Moore School of Business at the University of South Carolina, studying in Germany, England and Australia. He received his undergraduate degree in finance from the University of Notre Dame.